Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (VANISH 303)

ClinicalTrials.gov ID: NCT03734991

Public ClinicalTrials.gov record NCT03734991. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 3, randomized, multicenter, double-blind, placebo-controlled study to evaluate the efficacy and safety of oral Ibrexafungerp (SCY-078) compared to placebo in female subjects 12 years and older with AVVC.

Study identification

NCT ID
NCT03734991
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Scynexis, Inc.
Industry
Enrollment
376 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 4, 2019 (Actual)
Primary completion
Aug 21, 2019 (Actual)
Completion
Sep 4, 2019 (Actual)
Last update posted
Sep 8, 2021

2019

United States locations

U.S. sites
25
U.S. states
14
U.S. cities
23
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
Precision Trials AZ, LLC Phoenix Arizona 85032 —
Womens' Health Care Research Corp San Diego California 92111 —
Women's Medical Research Group Clearwater Florida 33759 —
Altus Research Lake Worth Florida 33461 —
OBGYN Assoc of Mid Florida Leesburg Florida 34748 —
New Age Medical Research Corporation Miami Florida 33186 —
Clinical Trials Management LLC Covington Louisiana 70006 —
Clinical Trials Management LLC Metairie Louisiana 70006 —
Unified Women's Clinical Research- Hagerstown Hagerstown Maryland 21740 —
Wayne State University Detroit Michigan 48201 —
Consultants In Women's Healthcare, Inc. St Louis Missouri 63131 —
Center For Women's Health and Wellness LLC - Interspond - PPDS Lawrenceville New Jersey 08648 —
Lawrence OB/GYN Clinical Research, LLC Lawrenceville New Jersey 08648 —
GYN Center for Women PA Durham North Carolina 27612 —
Carolina Women's Research and Wellness Center Durham North Carolina 27713 —
Unified Women's Clinical Research Greensboro Greensboro North Carolina 27408 —
Unified Women's Clinical Research Morehead City North Carolina 28557 —
Unified Women's Clinical Research Raleigh Raleigh North Carolina 27607 —
Unified Women's Clinical Research - Lyndhurst Clinical Research Winston-Salem North Carolina 27103 —
Medical Research South Charleston South Carolina 29414 —
Magnolia Ob/Gyn Research Center, LLC Myrtle Beach South Carolina 29572 —
Medical Research Center of Memphis Memphis Tennessee 38120 —
TMC Life Research Inc Houston Texas 77054 —
Group For Women Norfolk Virginia 23502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03734991, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 8, 2021 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03734991 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →